الفهرس 
Lung Cancer
Structure and membrane bindingOnly 14 pages are availabe for public view
 |  | from | 157 |  |  |
| | | from | 157 | | |
Abstract
Lung cancer is the leading cause of cancer-related mortality worldwide. the prognosis of lung cancer is still poor as we are still not able to diagnose lung cancer at an early stage.More effective molecular markers and diagnostic tools that can facilitate the diagnosis, prognosis, and therapy of lung cancer are needed.
Aim of the study The present study aimed to quantify annexin A1 levels in bronchoalveolar lavage fluid and in sera of all patients with lung cancer and non malignant lung diseases included in this study and to evaluate its role as a diagnostic aid for lung cancer.
Patients and methods This prospective analytic controlled case study was carried out in Chest Department,Tanta University Hospitals on 40 patients. The patients were classified into 2 groups: group 1:Included twenty patients diagnosed by histopathological examination as bronchogenic carcinoma. group 2:Included twenty patients who have non malignantlung diseases of known aetiologies (Pulmonary tuberculosis, Pneumonia, Lung abcess,Bronchiactasis). Inclusion criteria Patients with bronchogenic carcinoma[ 1st group ]. Patients with non malignant lung diseases of known etiology (Pneumonia, Lung abcess, bronchiactasis, TB) [2nd group].